Respiratory Disorder

Trusted pharma products in Respiratory Disorder

DALTEPARIN

Strength: 10000 IU

Form: Injection

Reference Brands:

View More Get Enquiry
DALTEPARIN

Strength: 2500IU

Form: Injection

Reference Brands:

View More Get Enquiry
DALTEPARIN

Strength: 5000IU

Form: 5000

Reference Brands:

View More Get Enquiry
Dextromethorphan Hbr + Bromhexine HCl + Guaiphenesin + Phenylepherine HCl + CPM Tablet

Strength: 15mg + 8mg + 100mg + 5mg + 4mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Diethyl Carbamazine Citrate + Cetirizine HCl Tablet

Strength: 150mg + 5mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Doxofylline

Strength: Tab: 200 mg, 400 mg; Syrup: 100 mg/5 mL

Form: Tablet & Syrup

Reference Brands: Doxolin®, Respiridox®(India)

View More Get Enquiry
Doxofylline Tablet

Strength: 400mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Ethofylline & Theophylline

Strength: 84.7 mg Ethofylline + 25.3 mg Theophylline

Form: Injection

Reference Brands: Deriphyllin® , Derin®

View More Get Enquiry
Ethofylline & Theophylline Injection

Strength: 84.7mg + 25.3mg/ml

Form: Injection

Reference Brands:

View More Get Enquiry
Fluticasone furoate + Vilanterol

Strength: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)

View More Get Enquiry
Fluticasone Propionate

Strength: 0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules

Form: Inhalation suspension for use with nebulizers

Reference Brands: Flixotide Nebules(EU)

View More Get Enquiry
Formoterol Fumarate And Budesonide

Strength: DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Symbicort®(US); Symbicort® Turbohaler®, DuoResp® Spiromax®(EU - various strengths available)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.